 |
Hemab
Last updated: January 17, 2024
Benny Sorensen, CEO
Country: Denmark | Funding: $190M (+)
Website: https://www.hemab.com/
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
Website: https://www.hemab.com/
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.